Home / Russia / Life Sciences & Healthcare

Life Sciences & Healthcare

We understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the life sciences & healthcare sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.


Feed

22/02/2023
SEAM­LESS Leg­al ex­perts re­cog­nised by the Pravo-300 rank­ing 2023
SEAM­LESS Leg­al ex­perts have earned re­cog­ni­tion by the Pravo-300 in­di­vidu­al rank­ing re­leased on 21 Feb­ru­ary 2023. The most reput­able Rus­si­an na­tion­al rank­ing has awar­ded 12 SEAM­LESS Leg­al law­yers across...
Press releases
01/02/2023
2022: Le­gis­lat­ive out­comes for the phar­ma­ceut­ic­al and med­ic­al device in­dus­tries
Since Feb­ru­ary 2022, busi­ness in Rus­sia has been af­fected by dra­mat­ic polit­ic­al and eco­nom­ic de­vel­op­ments. Mil­it­ary ac­tion and sanc­tions have giv­en rise to lo­gist­ic­al, man­u­fac­tur­ing and repu­ta­tion­al chal­lenges...
Event Webinar
20/01/2023
2022: Le­gis­lat­ive de­vel­op­ments im­pact­ing the phar­ma­ceut­ic­al and med­ic­al...
Since Feb­ru­ary 2022 busi­ness in Rus­sia has been af­fected by dra­mat­ic polit­ic­al and eco­nom­ic events. Mil­it­ary ac­tion and sanc­tions have giv­en rise to lo­gist­ic­al, man­u­fac­tur­ing and repu­ta­tion­al chal­lenges...
Publication
06/12/2022
SEAM­LESS Leg­al re­cog­nised by Pravo-300 2022
We are more than happy to share our first re­cog­ni­tion as SEAM­LESS Leg­al by the na­tion­al rank­ing Pravo.ru-300. This year SEAM­LESS Leg­al has earned 17 re­cog­ni­tions, in­clud­ing Band 1 award for the In­sur­ance...
News
31/08/2022
With­draw­al and de­struc­tion of im­prop­er med­ic­al devices: new rules
31 Au­gust 2022
Publication
18/07/2022
Rus­si­an Min­istry of In­dustry and Trade to have ac­cess to data of re­gis­tra­tion...
18 Ju­ly 2022
Publication
13/07/2022
Pro­ced­ure in­tro­duced to trans­fer mar­ket­ing au­thor­isa­tion cer­ti­fic­ates for...
13 Ju­ly 2022
Publication
15/06/2022
The former Mo­scow of­fice of CMS to con­tin­ue work­ing as an in­de­pend­ent law...
On 15 June 2022, the former Mo­scow of­fice of the in­ter­na­tion­al law firm CMS an­nounces the start of work as an in­de­pend­ent law firm un­der the new brand name SEAM­LESS Leg­al.Over 80 col­leagues of the Mo­scow of­fice con­tin­ue work­ing as one team, led by Man­aging Part­ner Jean-Fran­cois Mar­quaire and Seni­or Part­ner Le­onid Zubar­ev.We keep ad­vising our cli­ents across all 23 prac­tices and sec­tors: We lean on 30 years of ex­pert­ise and an im­pec­cable repu­ta­tion as part of an in­ter­na­tion­al law firm. We have al­ways abided by strict pro­fes­sion­al stand­ards and will con­tin­ue provid­ing ser­vices of the highest qual­ity. Jean-Fran­cois Mar­quaire, Man­aging Part­ner: “We are proud of hav­ing been able to cre­ate and pre­serve a united team with a friendly cor­por­ate cul­ture and re­spons­ible at­ti­tude to our busi­ness.”Le­onid Zubar­ev, Seni­or Part­ner: “Our new brand SEAM­LESS Leg­al most ac­cur­ately re­flects the ap­proach to work that has de­veloped over the years in our firm – in­teg­rity and co­her­ence, im­pec­cab­il­ity, con­tinu­ity and un­in­ter­rup­ted sup­port to our cli­ents at any time."
Press releases
09/06/2022
New grounds in­tro­duced for the im­port and sale of un­re­gistered medi­cines...
9 June 2022
Publication
15/03/2022
Latest le­gis­lat­ive ini­ti­at­ives in the Life Sci­ences sec­tor im­pact­ing for­eign...
There are plans to:pro­hib­it man­u­fac­tur­ers and dis­trib­ut­ors of med­ic­al devices from leav­ing the Rus­si­an mar­ket without at least six months pri­or no­tice; an­dper­mit the sale of for­eign medi­cines in their ori­gin­al pack­ages.Exit no­tice for man­u­fac­tur­ers and dis­trib­ut­ors of med­ic­al devicesThe Rus­si­an gov­ern­ment has de­veloped and in­tro­duced to the State Duma a bill* to amend the laws “On the ba­sics of pub­lic health pro­tec­tion in the Rus­si­an Fed­er­a­tion”, “On the cir­cu­la­tion of medi­cines” and “On the con­tract sys­tem in the pro­cure­ment of goods, works, ser­vices for state and mu­ni­cip­al needs”. To re­duce the risk of un­avail­ab­il­ity of med­ic­al devices and the threat to the life and health of cit­izens (in­clud­ing due to un­timely pro­vi­sion of med­ic­al care), there are plans to pro­hib­it man­u­fac­tur­ers and dis­trib­ut­ors of med­ic­al devices from sus­pend­ing or ter­min­at­ing the pro­duc­tion of med­ic­al devices or their im­port in­to Rus­sia without giv­ing the Rus­si­an Min­istry of Health no less than six months’ no­tice.Sale of for­eign medi­cines in their ori­gin­al pack­agesIt is pro­posed to ac­cel­er­ate the pro­cess of put­ting newly-re­gistered medi­cines on the Rus­si­an mar­ket. In case of their short­age (or the risk of short­age) while sanc­tions are in place, it will be pos­sible to im­port medi­cines, put them on the mar­ket and use them in Rus­sia in the ori­gin­al (i.e. for­eign) pack­aging without a Rus­si­an trans­la­tion.The rel­ev­ant bill* has already passed first read­ing and, if ad­op­ted, will come in­to force on the date of its of­fi­cial pub­lic­a­tion. Giv­en the prompt­ness of the ad­op­tion of counter-sanc­tions in Rus­sia, the ad­op­tion of this law can be ex­pec­ted in the com­ing days.* In Rus­si­an
Newsletter
14/03/2022
The Mo­scow of­fice of CMS to con­tin­ue as an in­de­pend­ent law firm
Dear FriendsWe have been through a lot dur­ing 30 years in Rus­sia. Now a dif­fi­cult de­cision has been taken by CMS to leave the Rus­si­an mar­ket. We are grate­ful to our in­ter­na­tion­al col­leagues for their...
News
28/01/2022
Leg­al de­vel­op­ments that may af­fect your busi­ness in 2022
CMS Rus­sia ex­perts have pre­pared their an­nu­al se­lec­tion of the most sig­ni­fic­ant leg­al de­vel­op­ments that may af­fect your busi­ness in Rus­sia in 2022.
Publication
Load more articles